Differentiation of n-1 Positional Isomers in Antisense Oligonucleotides with Orthogonal LCMS Methods
Journal of the American Society for Mass Spectrometry · 2025
DOI: 10.1021/jasms.5c00157 ↗At a glance
Journal article in Journal of the American Society for Mass Spectrometry, 2025. Written by Zifan Li and 9 co-authors. Institution: Pharmaceutical Operations & Technology, Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States. Major MEDLINE topics: Oligonucleotides, Antisense, Mass Spectrometry. Cited 1 times so far (Crossref); 27 references.
Abstract (original language)
Investigating the origin of critical product-related impurities during solid-phase synthesis is essential to improving the quality of therapeutic oligonucleotides. In the synthesis of a 2'-O-[2-(methylamino)-2-oxoethyl] modified phosphorothioate antisense oligonucleotide (NMA PS ASO), we observed elevated levels of n minus NMA 5-methylcytosine (n-NMA MeC), where n is the full-length product (FLP). This impurity, which results from the deletion of any of the five NMA MeC residues in the oligonucleotide sequence, is the major contributor to the n-1 class of impurities. High-resolution mass spectrometry cannot differentiate positional isomers arising from specific nucleotide deletions, because they are isobaric. Here, we compare two orthogonal approaches for the accurate differentiation of five isomeric n-NMA MeC impurities in a NMA PS ASO sample: (1) desulfurization to enhance chromatographic separation of the individual components of the composite n-NMA MeC impurity, thus enabling straightforward quantitation via LCMS, and (2) direct fragmentation of n-NMA MeC impurities to calculate the content of individual standards using their distinctive MS/MS fragments. Our strategies established the feasibility of resolving up to five isomeric n-1 impurities and allowed us to mitigate the risk of their formation during synthesis. The study results revealed that low coupling efficiency occurred at the NMA MeC nucleotides toward the 5' end of the sequence, which provided valuable insights into the sequence-specific challenges associated with synthesis efficiency and guided us to implement more effective n-1 control measures during the oligonucleotide synthetic process.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Pharmaceutical Operations & Technology, Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States.
ORCID profiles: Zifan Li, George M Bou-Assaf
Cite
APA
Li, Z., Kong, X., Zhou, X., Xiao, L., Phansalkar, R., Nguyen, T., Pickel, T. C., Cho, D., Zhou, X., & Bou-Assaf, G. M. (2025). Differentiation of n-1 Positional Isomers in Antisense Oligonucleotides with Orthogonal LCMS Methods. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.5c00157
Vancouver
Li Z, Kong X, Zhou X, Xiao L, Phansalkar R, Nguyen T, et al. Differentiation of n-1 Positional Isomers in Antisense Oligonucleotides with Orthogonal LCMS Methods. Journal of the American Society for Mass Spectrometry. 2025. doi:10.1021/jasms.5c00157
BibTeX
@article{Li2025,
author = {Li, Zifan and Kong, Xiaoqing and Zhou, Xiao and Xiao, Li and Phansalkar, Rasika and Nguyen, Tai and Pickel, Thomas C and Cho, David and Zhou, Xuan and Bou-Assaf, George M},
title = {Differentiation of n-1 Positional Isomers in Antisense Oligonucleotides with Orthogonal LCMS Methods},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2025},
doi = {10.1021/jasms.5c00157}
}
EUVIMED